Clincosm LogoSign in Get a demo

Relapsing-remitting Multiple Sclerosis

Showing 1 - 25 of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

Not yet recruiting
  • Relapsing-remitting Multiple Sclerosis
  • CT-P53
  • +2 more
  • (no location specified)
Jun 7, 2023

Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis Trial in France (Perfusion of treatment Rituximab, Perfusion of

Not yet recruiting
  • Multiple Sclerosis
  • Relapsing-remitting Multiple Sclerosis
  • Perfusion of treatment Rituximab
  • Perfusion of treatment Ocrelizumab
  • Lyon, Bron, France
  • +22 more
Mar 6, 2023

Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis Trial in West Orange (GEMS Plus, GEMS)

Recruiting
  • Multiple Sclerosis
  • Relapsing-remitting Multiple Sclerosis
  • GEMS Plus
  • GEMS
  • West Orange, New Jersey
    Kessler Foundation
Feb 23, 2023

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • La Jolla, California
  • +66 more
Jan 27, 2023

Tysabri Observational Program

Active, not recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Buenos Aires, Argentina
  • +421 more
Jan 23, 2023

Kesimpta for s.c. Injection 20 mg Pen

Recruiting
  • Relapsing-remitting Multiple Sclerosis
  • Active Secondary Progressive Multiple Sclerosis
  • Kesimpta
  • Ichinomiya, Aichi, Japan
  • +121 more
Jan 13, 2023

Generic Fingolimod in Relapsing-Remitting Multiple Sclerosis in

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Alexandria, Egypt
  • +1 more
Jun 14, 2022

Cladribine Tablets in Highly-active Relapsing Multiple Sclerosis

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
    • Coventry, United Kingdom
    • +7 more
    May 20, 2022

    Relapsing-remitting Multiple Sclerosis Trial in Stockholm (Rituximab)

    Active, not recruiting
    • Relapsing-remitting Multiple Sclerosis
    • Stockholm, Sweden
      Fredrik Piehl
    Apr 8, 2022

    Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,

    Terminated
    • Relapsing-Remitting Multiple Sclerosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Hamburg, Germany
    • +1 more
    Mar 1, 2022

    Relapsing-Remitting Multiple Sclerosis Trial in Columbus (Step Tracking, Water Tracking)

    Active, not recruiting
    • Relapsing-Remitting Multiple Sclerosis
    • Step Tracking
    • Water Tracking
    • Columbus, Ohio
      Department of Psychology, The Ohio State University
    Jan 24, 2022

    Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (dimethyl fumarate, Interferon ß-1a)

    Active, not recruiting
    • Relapsing-Remitting Multiple Sclerosis
    • dimethyl fumarate
    • Interferon β-1a
    • Boston, Massachusetts
    • +61 more
    Jan 12, 2022

    Relapsing-remitting Multiple Sclerosis Trial (BCD-063, Copaxone-Teva, Placebo)

    Completed
    • Relapsing-remitting Multiple Sclerosis
    • (no location specified)
    Sep 8, 2021

    Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

    Terminated
    Has Results
    • Relapsing-remitting Multiple Sclerosis
    • Rockland, Massachusetts
    • +1 more
    Jul 13, 2021

    Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

    Terminated
    Has Results
    • Relapsing-remitting Multiple Sclerosis
    • Rockland, Massachusetts
    • +1 more
    Jul 13, 2021

    Natural Killer Cells in Multiple Sclerosis Patients Treated With

    Terminated
    • Relapsing-Remitting Multiple Sclerosis
      • Berlin, Germany
        Charité Universitätsmedizin Berlin
      Jul 28, 2021

      Relapsing-remitting Multiple Sclerosis Trial in Berlin (epigallocatechin-gallate (Sunphenon), )

      Completed
      • Relapsing-remitting Multiple Sclerosis
      • epigallocatechin-gallate (Sunphenon)
      • placebo
      • Berlin, Germany
      • +1 more
      Jul 28, 2021

      Relapsing-remitting Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo, Tecfidera)

      Active, not recruiting
      Has Results
      • Relapsing-remitting Multiple Sclerosis
      • Blagoevgrad, Bulgaria
      • +55 more
      May 4, 2021

      Relapsing-Remitting Multiple Sclerosis Trial in Berlin (Prolonged Fasting, Ketogenic low glycemic load treatment, Control diet)

      Completed
      • Relapsing-Remitting Multiple Sclerosis
      • Prolonged Fasting
      • +2 more
      • Berlin, Germany
        Charité-Universitätsmedizin
      Apr 6, 2021

      Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

      Completed
      Has Results
      • Relapsing-remitting Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
        • London, United Kingdom
          Imperial College NHS Trust
        Feb 11, 2021

        Relapsing-Remitting Multiple Sclerosis Trial in Caen (Assessment of attentional functions by traditional tests, Assessment of

        Completed
        • Relapsing-Remitting Multiple Sclerosis
        • Assessment of attentional functions by traditional tests
        • +4 more
        • Caen, Basse-Normandie, France
        • +1 more
        Feb 25, 2021

        Relapsing-Remitting Multiple Sclerosis Trial in Hospitalet de Llobregat, Barcelona (Autologous peripheral blood differentiated

        Recruiting
        • Relapsing-Remitting Multiple Sclerosis
        • Autologous peripheral blood differentiated adult tolerogenic dendritic cells expanded
        • Placebo
        • Hospitalet de Llobregat, Barcelona, Spain
        • +4 more
        Feb 3, 2021

        Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (dimethyl fumarate, Placebo)

        Completed
        Has Results
        • Relapsing-Remitting Multiple Sclerosis
        • dimethyl fumarate
        • Placebo
        • Birmingham, Alabama
        • +245 more
        Dec 7, 2020

        Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo)

        Completed
        Has Results
        • Relapsing-Remitting Multiple Sclerosis
        • Boulder, Colorado
        • +116 more
        Nov 10, 2020

        Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis Trial in Worldwide (dimethyl fumarate)

        Completed
        • Relapsing-Remitting Multiple Sclerosis
        • Multiple Sclerosis
        • dimethyl fumarate
        • Innsbruck, Austria
        • +89 more
        Mar 18, 2020